Pharma & Biotech Companies Donate Hundreds of Millions of Dollars to Copayment Foundations. Here’s Why.

from BIOtechNow by biotechnow@bio.org (Biotechnology Industry Organization)

 

In addition to using their own Patient Assistance Programs, many pharma and biotech companies are supporting independent 501(c)3 non-profit copayment foundations to increase treatment compliance, access to care for insured Americans (including Medicare patients), and to promote proper disease management.

Mary P. Sundeen, President, HealthWell Foundation

Copayment foundations have helped hundreds of thousands of insured Americans afford their coverage and their treatments. The HealthWell Foundation, one of the nation’s largest non-profits, recently issued a white paper on copayment assistance as a primer for pharmaceutical and biotechnology personnel. Our goal is to assist with reducing a manufacturer’s exposure to legal pitfalls and to maximize their charitable donation.

for complete article:

Pharma & Biotech Companies Donate Hundreds of Millions of Dollars to Copayment Foundations. Here’s Why.